In mechanobiology, cells’ forces have been considered fundamental to their enhanced function, including fast migration.
Genfit, Ipsen tout pivotal trial readout for rare liver disease, head toward FDA and EMA submissions
Genfit and Ipsen announced Friday morning that their experimental treatment elafibranor helped patients with primary biliary cholangitis, a rare liver disease, see a decrease in
July 1, 2023